Table 2.

Healthcare resource utilization and costs at baseline for the subset of patients newly initiated on basal insulin with a 12-month follow-up

	Hypoglycemia cohort (n = 2495)	No hypoglycemia cohort (n = 53,113)	P value
Baseline all-cause healthcare utilization
Any hospitalization [n (%)]	1101 (44.1)	14,135 (26.6)	<0.001
Any ED visit [n (%)]	1312 (52.6)	20,277 (38.2)	<0.001
Baseline diabetes-related healthcare utilization
Any hospitalization [n (%)]	993 (39.8)	12,300 (23.2)	<0.001
Any ED visit [n (%)]	980 (39.3)	13,624 (25.7)	<0.001
Baseline all-cause healthcare costs
Total costs [mean (SD), $]	33,301 (59,318)	20,086 (44,771)	<0.001
ED costs [mean (SD), $]	987 (2596)	628 (1708)	<0.001
Baseline diabetes-related healthcare costs
Total costs [mean (SD), $]	10,026 (19,913)	5820 (12,464)	<0.001
ED costs [mean (SD), $]	425 (1441)	257 (987)	<0.001

ED emergency department, SD standard deviation